Last Updated: 10/18/23
Distribution of Grants
TRP currently uses the P50 (and the U54) funding mechanism for the SPORE program. In 2023, there were 60 funded SPOREs, covering 21 organ sites and systems, including one grant in cancer health disparities. The majority of grants used the P50 mechanism, and the remaining grants were funded through a U54 or P20 mechanism. In addition, TRP staff currently oversee a relatively smaller number of R21, R01, and R50 translational research grants. Grants below include those that are receiving funding and those that are in no-cost extensions.
| Organ Site | 2023 |
|---|---|
| Brain | 6 |
| Breast | 5 |
| Cervical | 1 |
| Disparities (Breast and Prostate) | 1 |
| Endometrial | 1 |
| Epigenetics | 1 |
| Gastrointestinal | 3 |
| Head & Neck/Thyroid | 4 |
| Kidney | 2 |
| Leukemia | 3 |
| Liver | 1 |
| Lung | 5 |
| Lymphoma | 1 |
| Myeloma | 2 |
| Ovarian | 5 |
| Pancreatic | 4 |
| Pediatric/Hyperactive RAS | 1 |
| Prostate | 7 |
| Radiation | 1 |
| Sarcoma | 1 |
| Skin/Melanoma | 5 |
| TOTAL SPOREs | 60 |